Penicillin Pharmacodynamics in Four Experimental Pneumococcal Infection Models
Open Access
- 1 April 2001
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (4), 1078-1085
- https://doi.org/10.1128/aac.45.4.1078-1085.2001
Abstract
Clinical and animal studies indicate that with optimal dosing, penicillin may still be effective against penicillin-nonsusceptible pneumococci (PNSP). The present study examined whether the same strains of penicillin-susceptible pneumococci (PSP) and PNSP differed in their pharmacodynamic responses to penicillin by using comparable penicillin dosing regimens in four animal models: peritonitis, pneumonia, and thigh infection in mice and tissue cage infection in rabbits. Two multidrug-resistant isolates of Streptococcus pneumoniae type 6B were used, one for which the penicillin MIC was 0.016 μg/ml and the other for which the penicillin MIC was 1.0 μg/ml. Two additional strains of PNSP were studied in the rabbit. The animals were treated with five different penicillin regimens resulting in different maximum concentrations of drugs in serum ( C max s) and times that the concentrations were greater than the MIC ( T >MIC s). The endpoints were bacterial viability counts after 6 h of treatment in the mice and 24 h of treatment in the rabbits. Similar pharmacodynamic effects were observed in all models. In the mouse models bactericidal activity depended on the T >MIC and to a lesser extent on the C max /MIC and the generation time but not on the area under the concentration-time curve (AUC)/MIC. Maximal bactericidal activities were similar for both PSP and PNSP, being the highest in the peritoneum and blood (∼6 log 10 CFU/ml), followed by the thigh (∼3 log 10 CFU/thigh), and being the lowest in the lung (∼1 log 10 CFU/lung). In the rabbit model the maximal effect was ∼6 log 10 CFU/ml after 24 h. In the mouse models bactericidal activity became marked when T >MIC was ≥65% of the experimental time and C max was ≥15 times the MIC, and in the rabbit model bactericidal activity became marked when T >MIC was ≥35%, C max was ≥5 times the MIC, and the AUC at 24 h/MIC exceeded 25. By optimization of the C max /MIC ratio and T >MIC , the MIC of penicillin for pneumococci can be used to guide therapy and maximize therapeutic efficacy in nonmeningeal infections caused by PNSP.Keywords
This publication has 25 references indexed in Scilit:
- Pneumonia Caused by Penicillin-non-susceptible and Penicillin-susceptible Pneumococci in Adults: A Case-Control StudyScandinavian Journal of Infectious Diseases, 1998
- Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal diseaseThe Pediatric Infectious Disease Journal, 1995
- Evidence for the Introduction of a Multiresistant Clone of Serotype 6B Streptococcus pneumoniae from Spain to Iceland in the Late 1980sThe Journal of Infectious Diseases, 1993
- Antimicrobial Resistance in Streptococcus pneumoniae: An OverviewClinical Infectious Diseases, 1992
- Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal ModelThe Journal of Infectious Diseases, 1988
- Experimental Infection with Streptococcus pneumoniae in Mice: Correlation of in Vitro Activity and Pharmacokinetic Parameters with in Vivo Effect for 14 CephalosporinsThe Journal of Infectious Diseases, 1986
- The Rate of Killing of Escherichia coli by -Lactam Antibiotics Is Strictly Proportional to the Rate of Bacterial GrowthMicrobiology, 1986
- Static and dynamic properties of tissue cage fluid in rabbitsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Spread of Streptococcus pneumoniae in Families. I. Carriage Rates and Distribution of TypesThe Journal of Infectious Diseases, 1975
- A RESISTANT PNEUMOCOCCUSThe Lancet, 1967